Switching of biologics in psoriasis: Reasons and results. [electronic resource]
Producer: 20180510Description: 1015-1019 p. digitalISSN:- 1346-8138
- Adalimumab -- therapeutic use
- Adult
- Aged
- Biological Products -- therapeutic use
- Dermatologic Agents -- therapeutic use
- Drug Substitution -- adverse effects
- Female
- Humans
- Infliximab -- therapeutic use
- Male
- Middle Aged
- Psoriasis -- drug therapy
- Retrospective Studies
- Severity of Illness Index
- Treatment Failure
- Treatment Outcome
- Ustekinumab -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.